Featured Article - Transforming Finance Operations: Beyond the Blockbuster Model

Is your finance team efficient, agile, and able to deliver services that support innovative business models?

Forward-thinking leaders in the life sciences industry are embracing transformation as a comprehensive means of ­improving cash flow, margins, revenue, and brand loyalty, which include developing a more strategic role for finance.

The life sciences industry is at an inflection point. The business model built on blockbuster drugs and high reimbursement rates can no longer be counted on to produce strong revenues and returns…

View the full article online

Featured Article: The Physician Payments Sunshine Act

More than a mere reporting exercise, it’s an opportunity to proactively engage with key customers to build stronger relationships, trust, and transparency.

Is your organization looking through the right lens?

Strategically, Genpact views this as an opportunity for life sciences manufacturer’s to differentiate themselves.

As engaging with key customers continues to be a challenge, are life sciences companies

looking at this as an opportunity or just a necessary evil?

View the full article online

Research Brief - CFOs on finance and procurement-process improvement

What do CFOs Say?

This research brief discusses process performance among medical companies (including health care, pharmaceuticals, biotechnology, and life sciences), specifically, by pointing out notable deviations from pan-industry averages.

Download white paper

See All PharmaVOICE White Papers

White Paper - Overcoming obstacles to transformation in the finance function

Finance & Accounting in the Life Sciences

EVPs, SVPs, VPs and senior directors of targeted life sciences and pharmaceutical companies were surveyed to determine the key challenges and priorities facing finance and accounting (F&A), finance administration and commercial operations. This paper shares the results.

Download white paper

See All PharmaVOICE White Papers

Five Keys to Successful Collaboration: Genpact and AstraZeneca Reveal What It Takes to Work Together

Organizations that believe a successful outsourcing partnership is built on a 400-page contract, an abundance of SLAs, and the sensation of stinging non-performance penalties are the same ones that, two years into a deal, spend millions of dollars on consultants to undo what went wrong. Avoiding that kind of scenario requires an outsourcing relationship that leverages five essential activities of collaboration, which are outlined in this case study.

Download case study

See All PharmaVOICE White Papers